Clinical Trial Update: Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow [NA]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the optimal dose for treating bone metastases with a novel STAT-RT workflow.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastasis

Snippet

Sponsor: Paul W. Read, MD | Conditions: Metastatic Bone Lesion | NA | Status: UNKNOWN